Potassium
Also called: potassium chloride, potassium citrate
Potassium is the most abundant intracellular cation and an essential nutrient; many fruits and vegetables, some legumes and potatoes are excellent sources. Supplements most often supply potassium chloride, and also citrate, phosphate, aspartate, bicarbonate or gluconate; labels declare elemental potassium.
- Category
- Mineral
- Forms
- Potassium chloride, citrate, phosphate, aspartate, bicarbonate, gluconate
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. ODS cites a 2017 meta-analysis of 25 RCTs (1,163 participants with hypertension) of potassium supplements, mostly potassium chloride at 30-120 mmol/day for 4-15 weeks, on blood pressure. [1]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels2 topics
BKidneys and bladder1 topic
CBlood sugar and weight1 topic
CBones and joints1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood pressure in adults | B | A meta-analysis (25 RCTs, 1,163 adults with hypertension, 30–120 mmol/day, 4–15 weeks) reported systolic 4.48 and diastolic 2.96 mmHg lower; a Cochrane review of six high-quality trials found nonsignificant reductions. [1] |
| Kidney stones (potassium citrate) | B | A 2015 Cochrane review (seven studies, 477 participants) found fewer new stones with potassium citrate; AHRQ judged supplement evidence insufficient. The proposed mechanism is citrate, not potassium itself. [1] |
| Stroke | C | A meta-analysis of 16 cohort studies associated the highest potassium intakes with a 13% lower stroke risk than the lowest (RR 0.87, 95% CI 0.80 to 0.94, adjusted for blood pressure). This is an observational association, not a supplement trial. [3] |
| Bone health | C | Trials of potassium citrate are mixed: one 2-year trial (201 adults 65+) improved spine bone density, while another (276 postmenopausal women, 2 years) found no significant gain. [1] |
| Blood glucose | C | Observational studies link low intake with higher diabetes risk; one small trial (29 adults with prediabetes, 40 mEq/day for 3 months) lowered fasting glucose only. [1] |
Main constituents: Potassium chloride (most common), citrate, phosphate, aspartate, bicarbonate, gluconate [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Adult AI: men 3,400 mg/day; women 2,600 mg/day; pregnancy 2,900 mg/day; lactation 2,800 mg/day (ages 19–50). No RDA. [1]
- Blood pressure trials used potassium chloride 30–120 mmol/day for 4–15 weeks. [1]
- Kidney stone trial: 30–60 mEq potassium citrate for 3 years (57 patients with hypocitraturia). [1]
- Potassium-only supplements usually contain up to 99 mg; multivitamin/minerals with potassium typically provide about 80 mg. [1]
Upper limits
- No UL has been set for potassium; the committee cited insufficient evidence. [1]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines3 listed
ACE inhibitors and angiotensin receptor blockers; Potassium-sparing diuretics (e.g. amiloride, spironolactone); Loop and thiazide diuretics
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications3 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- In healthy people with normal kidney function, high dietary potassium is not considered a risk; very large supplement doses can cause heart abnormalities, and acute hyperkalemia is possible if intake exceeds renal excretion. [1]
- People with chronic kidney disease, type 1 diabetes, congestive heart failure, adrenal insufficiency or liver disease can develop hyperkalemia even at intakes below the AI. [1]
- Hyperkalemia can cause muscle weakness, paralysis, palpitations, paresthesias and potentially life-threatening arrhythmias, or be asymptomatic. [1]
- Some oral potassium chloride drug products above 99 mg have been associated with small-bowel lesions. [1]
Interactions
| With | What happens |
|---|---|
| ACE inhibitors and ARBs | Reduce urinary potassium excretion and can cause hyperkalemia; monitoring is recommended, especially with impaired kidney function. [1] |
| Potassium-sparing diuretics (amiloride, spironolactone) | Reduce potassium excretion and can cause hyperkalemia; monitoring is recommended. [1] |
| Loop and thiazide diuretics | Increase potassium excretion and can cause hypokalemia; monitoring is recommended, with supplementation if warranted. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Labels list elemental potassium. Many manufacturers cap potassium at 99 mg per serving; FDA has not ruled on whether supplements above 99 mg need a warning label. [1]
Regulatory status
- US: sold as a dietary supplement ingredient. FDA Daily Value: 4,700 mg for adults and children age 4 and older. [1]
- FDAMA health claim notification for foods (October 31, 2000): "Diets containing foods that are good sources of potassium and low in sodium may reduce the risk of high blood pressure and stroke." Eligible foods must meet potassium, sodium, fat and cholesterol criteria. [2]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Potassium, supplied as potassium chloride (most common), citrate, phosphate, aspartate, bicarbonate or gluconate Mineral (potassium salts) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 3 entries naming potassium bicarbonate (earliest NDI 429 submitted 2006-11-07; most recent NDI 558 submitted 2008-08-05). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. No entry names potassium chloride, citrate, phosphate, aspartate or gluconate; other entries name potassium hydroxide, potassium iodide or potassium-containing complexes. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC carcinogenicity evaluation of potassium chloride, citrate, phosphate, aspartate, bicarbonate or gluconate was found (IARC Monographs list of classifications checked 2026-10-29). [P2]
- No NTP carcinogenicity technical report on potassium chloride, citrate, phosphate, aspartate, bicarbonate or gluconate was found (NTP technical reports list checked 2026-10-29). [P3]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- ACE inhibitors and angiotensin receptor blockers: These medications reduce urinary potassium excretion, which can lead to hyperkalemia; experts recommend monitoring potassium status. [P5]
- Potassium-sparing diuretics (e.g. amiloride, spironolactone): Reduce the excretion of potassium in the urine and can cause hyperkalemia; experts recommend monitoring potassium status. [P5]
- Loop and thiazide diuretics: Increase urinary potassium excretion and can lead to hypokalemia; experts recommend monitoring potassium status. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition-based exemption under 111.75(a)(1)(ii). [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- The body absorbs an estimated 85%-90% of dietary potassium, by passive diffusion, primarily in the small intestine. [P5]
- One study found humans absorb about 94% of potassium gluconate in supplements, similar to potassium from potatoes; enteric-coated potassium chloride tablets are not absorbed as rapidly as liquid forms. Only a few studies have examined how well the various forms in supplements are absorbed. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (list last updated 2026-07-23 per page data; checked 2026-10-29), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- NIH Office of Dietary Supplements. Potassium: Fact Sheet for Health Professionals (Updated: June 2, 2022), 2022-06-02. ods.od.nih.gov
Sources
- NIH Office of Dietary Supplements. Potassium: Fact Sheet for Health Professionals (updated 2022-06-02), 2022-06-02. ods.od.nih.gov
- US Food and Drug Administration. Health Claim Notification for Potassium Containing Foods (October 31, 2000), 2000-10-31. fda.gov
- Vinceti M, et al. Meta-analysis of potassium intake and the risk of stroke. J Am Heart Assoc 2016;5(10):e004210 (PMID 27792643), 2016-10-06. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in mineral: Boron · Calcium · Chromium · Copper · Iodine · Iron · Magnesium · Manganese · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.